Abstract:Human immunodeficiency virus (HIV)-1 exhibits remarkable genetic diversity. For this reason, an effective HIV-1 vaccine must elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected individuals, a general understanding of the virus-antibody coevolutionary processes that lead to their development remains incomplete. We performed a quantitative study of HIV-1 evolution in two individuals who developed bnAbs. We observed strong selection early in infection for mutations affecting HIV-1 envelope glycosylation and escape from autologous strain-specific antibodies, followed by weaker selection for bnAb resistance later in infection. To confirm our findings, we analyzed data from rhesus macaques infected with viruses derived from the same two individuals. We inferred remarkably similar fitness effects of HIV-1 mutations in humans and macaques. Moreover, we observed a striking pattern of rapid HIV-1 evolution, consistent in both humans and macaques, that precedes the development of bnAbs. Our work highlights strong parallels between infection in rhesus macaques and humans, and it reveals a quantitative evolutionary signature of bnAb development.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand how the HIV - 1 virus evolves during the infection process, especially in individuals who can produce broadly neutralizing antibodies (bnAbs). Specifically, the research aims to: 1. **Quantify the evolutionary dynamics of HIV - 1**: By analyzing the evolutionary patterns of HIV - 1 in humans and rhesus monkeys, researchers hope to reveal the mechanisms by which the virus adapts to the host immune system. 2. **Identify the selection pressures leading to bnAb development**: Researchers focused on which mutations are beneficial to the virus and how these mutations affect the co - evolution of the virus and antibodies. 3. **Compare the HIV - 1 evolutionary patterns in humans and rhesus monkeys**: By using SHIV (simian - human immunodeficiency viruses) containing the HIV - 1 envelope protein (Env), researchers hope to determine the similarities and differences in virus evolution in humans and non - human primates. ### Research Background HIV - 1 has extremely high genetic diversity, which makes it very difficult to develop an effective vaccine. Although broadly neutralizing antibodies (bnAbs) have been isolated from HIV - 1 - infected individuals, the understanding of their development process is still incomplete. In order to better understand the bnAb development mechanism, researchers conducted a quantitative study to analyze the changes in selection pressures in the early and late stages of HIV - 1 infection. ### Main Findings 1. **Early selection pressures focus on envelope glycosylation and escape from self - response**: The study found that in the early stage of infection, the virus is mainly under selection pressure to change envelope glycosylation sites and escape from self - response, rather than to resist broadly neutralizing antibodies. 2. **Rapid adaptive gain is associated with bnAb development**: In individuals who develop broadly neutralizing antibodies, a rapid gain in virus adaptability was observed. 3. **Similar evolutionary patterns in humans and rhesus monkeys**: Researchers found that the evolutionary patterns of HIV - 1 in humans and rhesus monkeys are very similar, especially in terms of selection pressures. ### Methods Researchers used data from two individuals (CH505 and CH848) who developed bnAbs and quantified the impact of each mutation on virus adaptability by inferring selection coefficients. In addition, they also studied rhesus monkeys infected with SHIV to verify whether these findings can be generalized to other model systems. ### Conclusions This study shows that HIV - 1 exhibits specific evolutionary patterns in individuals who develop broadly neutralizing antibodies, and these patterns can be identified through quantitative analysis. The research results not only deepen the understanding of the evolutionary dynamics of HIV - 1, but also provide important clues for future vaccine design. ### Formula Representation The selection coefficient \( s_i(a) \) involved in the article is used to quantify the impact of each mutation on virus adaptability, where: - \( s_i(a)>0 \) represents a beneficial mutation - \( s_i(a)<0 \) represents a harmful mutation The overall adaptability \( F \) of the virus can be calculated by the following formula: \[ F=\sum_{i} s_i(a) \] where \( i \) represents the genomic position and \( a \) represents the mutation type at that position. ### Summary This study reveals the relationship between virus adaptive gain and the development of broadly neutralizing antibodies by quantitatively analyzing the evolutionary patterns of HIV - 1 in humans and rhesus monkeys, providing important insights into understanding the evolutionary dynamics of HIV - 1.

Parallel HIV-1 fitness landscapes shape viral dynamics in humans and macaques that develop broadly neutralizing antibodies.

Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth

Development of Antibodies with Broad Neutralization Specificities Against HIV-1 after Long Term SHIV Infection in Macaques

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates

Viral Envelope Evolution in Simian–HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques

Recapitulation of HIV-1 Neutralization Breadth in Plasma by the Combination of Two Broadly Neutralizing Antibodies from Different Lineages in the Same SHIV-Infected Rhesus Macaque

SIV Infection Duration Largely Determines Broadening of Neutralizing Antibody Response in Macaques.

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth

Host-pathogen coevolution and the emergence of broadly neutralizing antibodies in chronic infections

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Development of broad neutralization activity in SHIV-infected rhesus macaques after long-term infection.

A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody

The Potential Of The Human Immune System To Develop Broadly Neutralizing Hiv-1 Antibodies: Implications For Vaccine Development

HIV-1 neutralizing antibodies in SHIV-infected macaques recapitulate structurally divergent modes of human V2 apex recognition with a single D gene

Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody

Stronger Binding Affinities of gp120/CD4 in Catarrhini Provide Insights into HIV/Host Interactions

A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope

Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques

Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2